JP2023540756A5 - - Google Patents
Info
- Publication number
- JP2023540756A5 JP2023540756A5 JP2023514976A JP2023514976A JP2023540756A5 JP 2023540756 A5 JP2023540756 A5 JP 2023540756A5 JP 2023514976 A JP2023514976 A JP 2023514976A JP 2023514976 A JP2023514976 A JP 2023514976A JP 2023540756 A5 JP2023540756 A5 JP 2023540756A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074548P | 2020-09-04 | 2020-09-04 | |
| US63/074,548 | 2020-09-04 | ||
| PCT/US2021/049081 WO2022051633A2 (en) | 2020-09-04 | 2021-09-03 | Novel engineered capsid serotype of recombinant adeno-associated viral vector with enhanced transduction efficiency and widespread distribution in the brain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023540756A JP2023540756A (ja) | 2023-09-26 |
| JPWO2022051633A5 JPWO2022051633A5 (https=) | 2024-09-11 |
| JP2023540756A5 true JP2023540756A5 (https=) | 2024-09-11 |
Family
ID=80491526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514976A Pending JP2023540756A (ja) | 2020-09-04 | 2021-09-03 | 向上した形質導入効率及び脳内における広範な分布を有する組換えアデノ随伴ウイルスベクターの新規の操作されたキャプシド血清型 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230330267A1 (https=) |
| EP (1) | EP4208557A4 (https=) |
| JP (1) | JP2023540756A (https=) |
| CN (1) | CN116249541A (https=) |
| AU (1) | AU2021335601A1 (https=) |
| CA (1) | CA3191543A1 (https=) |
| WO (1) | WO2022051633A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240158861A1 (en) * | 2021-04-23 | 2024-05-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for treating cell senescence accumulation related disease |
| WO2025059678A1 (en) * | 2023-09-15 | 2025-03-20 | Ohio State Innovation Foundation | Novel engineered capsid serotypes of recombinant adeno-associated viral vectors with reduced liver tropism |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1486567A1 (en) * | 2003-06-11 | 2004-12-15 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Improved adeno-associated virus (AAV) vector for gene therapy |
| WO2009120978A2 (en) * | 2008-03-27 | 2009-10-01 | The Ohio State University | Treatment of metabolic-related disorders using hypothalamic gene transfer of bdnf and compositions therfor |
| IL248102B (en) * | 2014-05-02 | 2022-07-01 | Genzyme Corp | aav vectors for gene therapy of the central nervous system and retina |
| MX2020002148A (es) * | 2017-08-25 | 2020-07-20 | Ovid Therapeutics Inc | Vectores adenoasociados recombinantes. |
| EP3793615A2 (en) * | 2018-05-16 | 2021-03-24 | Voyager Therapeutics, Inc. | Directed evolution of aav to improve tropism for cns |
-
2021
- 2021-09-03 AU AU2021335601A patent/AU2021335601A1/en not_active Abandoned
- 2021-09-03 JP JP2023514976A patent/JP2023540756A/ja active Pending
- 2021-09-03 CA CA3191543A patent/CA3191543A1/en active Pending
- 2021-09-03 EP EP21865201.4A patent/EP4208557A4/en active Pending
- 2021-09-03 WO PCT/US2021/049081 patent/WO2022051633A2/en not_active Ceased
- 2021-09-03 US US18/024,806 patent/US20230330267A1/en active Pending
- 2021-09-03 CN CN202180054939.4A patent/CN116249541A/zh active Pending